Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R).
Article Details
- CitationCopy to clipboard
Roetto A, Daraio F, Porporato P, Caruso R, Cox TM, Cazzola M, Gasparini P, Piperno A, Camaschella C
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R).
Blood. 2004 Mar 15;103(6):2407-9. doi: 10.1182/blood-2003-10-3390. Epub 2003 Nov 20.
- PubMed ID
- 14630809 [ View in PubMed]
- Abstract
Juvenile or type 2 hemochromatosis (JH) is a genetic disease caused by increased intestinal iron absorption that leads to early massive iron overload. The main form of the disease is caused by mutations in a still unknown gene on chromosome 1q. Recently, we recognized a second type of JH with clinical features identical to the 1q-linked form, caused by mutations in the gene encoding hepcidin (HEPC). Hepcidin is a hepatic antimicrobial-like peptide whose role in iron homeostasis was first defined in animal models; deficiency of hepcidin in mice leads to iron overload, whereas its hepatic overexpression in transgenic animals causes iron deficiency. To define the prevalence of HEPC mutations in JH we screened the HEPC gene for mutation in 21 unrelated JH subjects. We identified a new mutation (C70R), which affects 1 of the 8 conserved cysteines that form the disulfide bonds and are critical for the stability of the polypeptide.